Yiling Pharmaceutical’s Lianhua Qingwen capsules have been out of stock in many parts of the country, with prices more than doubling in the southwestern city of Chengdu. Photo: SCMP Handout
Yiling Pharmaceutical’s Lianhua Qingwen capsules have been out of stock in many parts of the country, with prices more than doubling in the southwestern city of Chengdu. Photo: SCMP Handout

Stock traders pile into makers of cold medicines, antigen test kits as China’s shift from zero-Covid spurs demand

  • Stock traders are quickly changing tack with their Covid-19 bets to position for China’s shift away from its harsh pandemic restrictions
  • Shijiazhuang Yiling Pharmaceutical, whose traditional Chinese cold medicine is officially used to treat Covid-19, has surged in the past month

Yiling Pharmaceutical’s Lianhua Qingwen capsules have been out of stock in many parts of the country, with prices more than doubling in the southwestern city of Chengdu. Photo: SCMP Handout
Yiling Pharmaceutical’s Lianhua Qingwen capsules have been out of stock in many parts of the country, with prices more than doubling in the southwestern city of Chengdu. Photo: SCMP Handout
READ FULL ARTICLE